Engineering functional bladder tissues

Journal of Tissue Engineering and Regenerative Medicine

Volumn 7, Issue 7, 2013, Pages 515-522

  Horst, Maya ^a   Madduri, Srinivas ^a   Gobet, Rita ^c   Sulser, Tullio ^a   Milleret, Vinzent ^b   Hall, Heike ^b   Atala, Anthony ^d   Eberli, Daniel ^a  

^a UNIVERSITY HOSPITAL ZURICH   (Switzerland)

^b ETH ZURICH   (Switzerland)

^c UNIVERSITY CHILDREN S HOSPITAL   (Switzerland)

^d WAKE FOREST SCHOOL OF MEDICINE   (United States)

Author keywords

Bioengineering; Functional bladder tissue; Innervation; Scaffolds; Vascularization

Indexed keywords

CELL ENGINEERING; DISTRIBUTED COMPUTER SYSTEMS; HISTOLOGY; SCAFFOLDS (BIOLOGY); TISSUE;

'CURRENT; BIOENGINEERING; BLADDER TISSUE; FUNCTIONAL BLADDER TISSUE; FUNCTIONAL TISSUE; INNERVATION; QUALITY OF LIFE; TISSUE-ENGINEERING TECHNIQUES; TISSUES ENGINEERINGS; VASCULARIZATION;

RESTORATION;

BIOMATERIAL; COLLAGEN; POLYGLACTIN; POLYGLYCOLIC ACID; POLYLACTIC ACID; POLYMER; TISSUE SCAFFOLD;

BLADDER; BLADDER CONTRACTION; BLADDER RECONSTRUCTION; EXTRACELLULAR MATRIX; MEDLINE; MICROENVIRONMENT; MICTURITION; PRIORITY JOURNAL; REVIEW; TISSUE ENGINEERING; VASCULARIZATION;

EID: 84879553816     PISSN: 19326254     EISSN: 19327005     Source Type: Journal    
DOI: 10.1002/term.547     Document Type: Review

References (57)

1. Aitken KJ, Bagli DJ. 2009; The bladder extracellular matrix. Part 1: architecture, development and disease. Nat Rev Uro 6: 596-611.
2. Askari A, Unzek S, Goldman CK et al. 2004; Cellular, but not direct, adenoviral delivery of vascular endothelial growth factor results in improved left ventricular function and neovascularization in dilated ischemic cardiomyopathy. J Am Coll Cardiol 43: 1908-1914.
3. Atala A, Bauer SB, Soker S et al. 2006; Tissue-engineered autologous bladders for patients needing cystoplasty. Lancet 367: 1241-1246.
4. Baumert H, Simon P, Hekmati M et al. 2007; Development of a seeded scaffold in the great omentum: feasibility of an in vivo bioreactor for bladder tissue engineering. Eur Urol 52: 884-890.
5. Bouhout S, Perron E, Gauvin R et al. 2010; In vitro reconstruction of an autologous, watertight, and resistant vesical equivalent. Tissue Eng Part A 16: 1539-1548.
6. Brivanlou AH, Gage FH, Jaenisch R et al. 2003; Stem cells. Setting standards for human embryonic stem cells. Science 300: 913-916.
7. Brown A, Farhat W, Merguerian P et al. 2002; 22 week assessment of bladder acellular matrix as a bladder augmentation material in a porcine model. Biomaterials 23: 2179-2190.
8. Chen W, Shi C, Yi S et al. 2010; Bladder regeneration by collagen scaffolds with collagen binding human basic fibroblast growth factor. J Urol 183: 2432-2439.
9. Chun SY, Lim GJ, Kwon TG et al. 2007; Identification and characterization of bioactive factors in bladder submucosa matrix. Biomaterials 28: 4251-4256.
10. Chung SY, Krivorov NP, Rausei V et al. 2005; Bladder reconstitution with bone marrow derived stem cells seeded on small intestinal submucosa improves morphological and molecular composition. J Urol 174: 353-359.
11. Corey JM, Lin DY, Mycek KB et al. 2007; Aligned electrospun nanofibers specify the direction of dorsal root ganglia neurite growth. J Biomed Mater Res A 83a: 636-645.
12. Dozmorov MG, Kropp BP, Hurst RE et al. 2007; Differentially expressed gene networks in cultured smooth muscle cells from normal and neuropathic bladder. J Smooth Muscle Res 43: 55-72.
13. Eberli D, Freitas Filho L, Atala A et al. 2009; Composite scaffolds for the engineering of hollow organs and tissues. Methods 47: 109-115.
14. Elder BD, Athanasiou KA. 2009; Hydrostatic pressure in articular cartilage tissue engineering: from chondrocytes to tissue regeneration. Tissue Eng Part B Rev 15: 43-53.
15. Farhat WA, Yeger H. 2008; Does mechanical stimulation have any role in urinary bladder tissue engineering? World J Urol 26: 301-305.
16. Fauza D. 2004; Amniotic fluid and placental stem cells. Best Pract Res Clin Obstet Gynaecol 18: 877-891.
17. Ferrara N, Davis-Smyth T. 1997; The biology of vascular endothelial growth factor. Endocr Rev 18: 4-25.
18. Gerber HP, Dixit V, Ferrara N. 1998; Vascular endothelial growth factor induces expression of the antiapoptotic proteins BCL-2 and A1 in vascular endothelial cells. J Biol Chem 273: 13313-13316.
19. Haberstroh KM, Kaefer M., Depaola N et al. 2002; A novel in vitro system for the simultaneous exposure of bladder smooth muscle cells to mechanical strain and sustained hydrostatic pressure. J Biomech Eng 124: 208-213.
20. Hipp JA, Hipp JD, Yoo JJ et al. 2008; Microarray analysis of bladder smooth muscle from patients with myelomeningocele. BJU Int 102: 741-746.
21. Hubschmid U, Leong-Morgenthaler PM, Basset-Dardare A et al. 2005; In vitro growth of human urinary tract smooth muscle cells on laminin and collagen type 1-coated membranes under static and dynamic conditions. Tissue Eng 11: 161-171.
22. Hutmacher DW. 2000; Scaffolds in tissue engineering bone and cartilage. Biomaterials 21: 2529-2543.
23. Jack GS, Zhang R, Lee M et al. 2009; Urinary bladder smooth muscle engineered from adipose stem cells and a three dimensional synthetic composite. Biomaterials 30: 3259-3270.
24. Kanematsu A, Yamamoto S, Ozeki M et al. 2004; Collagenous matrices as release carriers of exogenous growth factors. Biomaterials 25: 4513-4520.
25. Kikuno N, Kawamoto K, Hirata H et al. 2009; Nerve growth factor combined with vascular endothelial growth factor enhances regeneration of bladder acellular matrix graft in spinal cord injury-induced neurogenic rat bladder. BJU Int 103: 1424-1428.
26. Ko HC, Milthorpe BK, Mcfarland CD. 2007; Engineering thick tissues--the vascularisation problem. Eur Cell Mater 14: 1-18; discussion 18-19.
27. Kropp BP, Rippy MK, Badylak SF et al. 1996; Regenerative urinary bladder augmentation using small intestinal submucosa: urodynamic and histopathologic assessment in long-term canine bladder augmentations. J Urol 155: 2098-2104.
28. Madduri S, Papaloizos M, Gander B. 2009; Synergistic effect of GDNF and NGF on axonal branching and elongation in vitro. Neurosci Res 65(1): 88-97. Epub 2009 Jun 11.
29. Mauney JR, Cannon GM, Lovett ML et al. 2011; Evaluation of gel spun silk-based biomaterials in a murine model of bladder augmentation. Biomaterials 32: 808-818.
30. Mauney JR, Ramachandran A, Yu RN et al. 2010; All-trans retinoic acid directs urothelial specification of murine embryonic stem cells via GATA4/6 signaling mechanisms. PLoS One 5: e11513.
31. Moreau JE, Bramono DS, Horan RL et al. 2008; Sequential biochemical and mechanical stimulation in the development of tissue-engineered ligaments. Tissue Eng Part a 14: 1161-1172.
32. Nakanishi Y, Chen G, Komuro H et al. 2003; Tissue-engineered urinary bladder wall using plga mesh-collagen hybrid scaffolds: a comparison study of collagen sponge and gel as a scaffold. J Pediatr Surg 38: 1781-1784.
33. Nitta M, Tamaki T, Tono K et al. 2010; Reconstitution of experimental neurogenic bladder dysfunction using skeletal muscle-derived multipotent stem cells. Transplantation 89: 1043-1049.
34. Oberpenning F, Meng J, Yoo JJ. et al. 1999; De novo reconstitution of a functional mammalian urinary bladder by tissue engineering. Nat Biotechnol 17: 149-155.
35. Okita K. 2010. IPS cells for transplantation. Curr Opin Organ Transplant Dec 9. [Epub ahead of print]
36. Pariente JL, Kim BS, Atala A. 2002; In vitro biocompatibility evaluation of naturally derived and synthetic biomaterials using normal human bladder smooth muscle cells. J Urol 167: 1867-1871.
37. Peppas NA, Langer R. 1994; New challenges in biomaterials. Science 263: 1715-1720.
38. Piquilloud G, Christen T, Pfister LA et al. 2007. Variations in glial cell line-derived neurotrophic factor release from biodegradable nerve conduits modify the rate of functional motor recovery after rat primary nerve repairs. Eur J Neurosci 26: 1109-1117.
39. Raghavan AM, Shenot PJ. 2009; Bladder augmentation using an autologous neo-bladder construct. Kidney Int 76: 236.
40. Reddy PP, Barrieras DJ, Wilson G et al. 2000; Regeneration of functional bladder substitutes using large segment acellular matrix allografts in a porcine model. J Urol 164: 936-941.
41. Sasaki K, Chancellor MB, Goins WF et al. 2004; Gene therapy using replication-defective herpes simplex virus vectors expressing nerve growth factor in a rat model of diabetic cystopathy. Diabetes 53: 2723-2730.
42. Schnegelsberg B, Sun TT, Cain G et al. 2010; Overexpression of ngf in mouse urothelium leads to neuronal hyperinnervation, pelvic sensitivity, and changes in urinary bladder function. Am J Physiol Regul Integr Comp Physiol 298: r534-547.
43. Schultheiss D, Gabouev AI, Cebotari S et al. 2005; Biological vascularized matrix for bladder tissue engineering: matrix preparation, reseeding technique and short-term implantation in a porcine model. J Urol 173: 276-280.
44. Seliktar D, Black RA, Vito RP et al. 2000; Dynamic mechanical conditioning of collagen-gel blood vessel constructs induces remodeling in vitro. Ann Biomed Eng 28: 351-362.
45. Sievert KD, Amend B, Stenzl A. 2007; Tissue engineering for the lower urinary tract: a review of a state of the art approach. Eur Urol 52: 1580-1589.
46. Sutherland RS, Baskin LS, Hayward S et al. 1996; Regeneration of bladder urothelium, smooth muscle, blood vessels and nerves into an acellular tissue matrix. J Urol 156: 571-577.
47. Takada Y, Ye X, Simon S. 2007; The integrins. Genome Biol 8: 215.
48. Takahashi K, Yamanaka S. 2006; Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell 126: 663-676.
49. Tanaka ST, Thangappan R, Eandi JA et al. 2010; Bladder wall transplantation-long-term survival of cells: implications for bioengineering and clinical application. Tissue Eng Part A 16(6): 2121-2127
50. Wallis MC, Yeger H, Cartwright L et al. 2008; Feasibility study of a novel urinary bladder bioreactor. Tissue Eng Part A 14: 339-348.
51. Xie C, Hu J, Ma H et al. 2011; Three-dimensional growth of IPS cell-derived smooth muscle cells on nanofibrous scaffolds. Biomaterials 32: 4369-4375.
52. Xu CY, Inai R, Kotaki M et al. 2004; Aligned biodegradable nanofibrous structure: a potential scaffold for blood vessel engineering. Biomaterials 25: 877-886.
53. Yamanaka M, Shirai M, Shiina H et al. 2002; Loss of anti-apoptotic genes in aging rat crura. J Urol 168: 2296-2300.
54. Yang B, Zhang Y, Zhou L et al. 2010; Development of a porcine bladder acellular matrix with well-preserved extracellular bioactive factors for tissue engineering. Tissue Eng Part C Methods 16: 1201-1211.
55. Yang S, Lin G, Tan Y et al. 2008; Tumor progression of culture-adapted human embryonic stem cells during long-term culture. Genes Chromosomes Cancer 47: 665-679.
56. Zhang Y, Frimberger D, Cheng EY et al. 2006; Challenges in a larger bladder replacement with cell-seeded and unseeded small intestinal submucosa grafts in a subtotal cystectomy model. BJU Int 98: 1100-1105.
57. Zhou H, Ding S. 2010; Evolution of induced pluripotent stem cell technology. Curr Opin Hematol 17: 276-280.